Section Arrow
Quote
ZLAB.NASDAQ
- Zai Lab Limited
Quotes are at least 15-min delayed:2026/09/21 23:05 EDT
Regular Hours
Last
 26.43
+0.73 (+2.84%)
Day High 
26.72 
Prev. Close
25.7 
1-M High
27.5 
Volume 
1.18M 
Bid
26.06
Ask
27.1
Day Low
26.16 
Open
26.64 
1-M Low
23.64 
Market Cap 
2.89B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 25.06 
20-SMA 25.58 
50-SMA 23.1 
52-W High 34.72 
52-W Low 15.96 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.70/-0.24
Enterprise Value
2.90B
Balance Sheet
Book Value Per Share
5.41
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
460.16M
Operating Revenue Per Share
2.35
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
RXRXRecursion Pharmaceuticals3.97+0.14+3.66%-- 
MRNAModerna172.94+18.9+12.27%-- 
SLXNSilexion Therapeutics Corp.0.5441+0.1086+24.94%-- 
CELZCreative Medical Technology Holdings1.005+0.0391+4.05%-- 
PDSBPDS Biotechnology Corp0.8419+0.0364+4.52%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.